Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Swartz Analytical Techniques in Combinatorial Chemistry

.pdf
Скачиваний:
16
Добавлен:
15.08.2013
Размер:
2.27 Mб
Скачать

ISBN: 0-8247-1939-5

This book is printed on acid-free paper.

Headquarters

Marcel Dekker, Inc.

270 Madison Avenue, New York, NY 10016 tel: 212-696-9000; fax: 212-685-4540

Eastern Hemisphere Distribution

Marcel Dekker AG

Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland tel: 41-61-261-8482; fax: 41-61-261-8896

World Wide Web

http://www.dekker.com

The publisher offers discounts on this book when ordered in bulk quantities. For more information, write to Special Sales/Professional Marketing at the headquarters address above.

Copyright 2000 by Marcel Dekker, Inc. All Rights Reserved.

Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval system, without permission in writing from the publisher.

Current printing (last digit):

 

 

10

9

8

7

6

5

4

3

2

1

PRINTED IN THE UNITED STATES OF AMERICA

Foreword: Chemistry Becomes an

Information Science

Nothing in recent years has had as great an impact on the process of drug discovery as the rise of genomics and combinatorial chemistry. Nothing has been more urgently needed. In the United States today it takes an average of 13 years and over $300 million to develop a drug. Although regulatory hurdles account for a good portion of those costs, major difficulties lie in two other areas.

First, there are not enough drug targets. There are about 6000 known drugs, half of which hit human targets. However, those 3000 human-directed drugs hit only about 500 targets, which means that less than 1% of the human genome (estimated to contain 80,000 to 100,000 genes) has been exploited pharmaceutically. It’s even worse for antimicrobial drugs. Consider antifungal agents: almost every marketed antifungal agent hits one of a handful of targets in the same metabolic pathway. Genomics, the science of identifying and sequencing all of the genes in an organism, is changing all this at an astonishing rate. Soon we will have a plethora of targets, for pathogens and people. However, this only makes the second difficulty—that there aren’t enough drugs— more acute.

Those 6000 known drugs fall into only around 300 chemical classes (the exact figure depends on how one defines a ‘‘class’’). Recently, a major pharmaceutical company screened its entire compound inventory—over 400,000 compounds developed over almost 100 years of work—against a new target identified by genomics. They did not find a single hit. This sounds surprising until one examines that inventory closely: almost half the compounds in it could be considered to be derived from a single chemical class.

It is this problem that combinatorial chemistry is designed to solve, and its explosive growth is testimony to both the magnitude of the problem and

iii

iv

Foreword

the early successes of the combinatorial approach. Combinatorial chemistry has many guises. In its purest form it involves the synthesis of all possible compounds from a set of modular building blocks. However, it can also mean high-throughput parallel synthesis of individual pure compounds, simultaneous synthesis of mixtures of compounds free in solution or on solid support, or a number of other variations on these themes. Regardless of the details of the process, the objective is the same: to produce a large number of chemically ‘‘diverse’’ compounds as rapidly as possible.

And that it does. Combinatorial methods have rewriten the standards for synthetic productivity. Until about 10 years ago, a good chemist could make and characterize perhaps 50 compounds per year. A combinatorial chemist aims for more like 50,000. Such numbers define a revolution, one that has already transformed the pharmaceutical industry and is likely to eventually make an impact on every other area of industrial chemistry. Analytical chemistry is no exception, which brings us to the subject of this splendid book.

It is, of course, one thing to make 50,000 compounds and quite another to know what one has made. Yet that is essential, because when new molecules are available in such staggering numbers chemistry has become an information science. Consider a chemically ‘‘diverse’’ (whatever that means, and nobody really knows yet) library of 50,000 compounds. Now screen that against, say, 50 different drug targets. Then imagine that you don’t know what any of the compounds are. The ones that give ‘‘hits’’ in your assays won’t remain unknown for long: you will purify those and characterize them. Yet in doing so, you will throw information away. If you knew the structure of every compound, then the ones that failed in your assays would be almost as valuable to you as the ones that succeeded because they would define the chemical types that were not likely to work for that particular set of target classes. Combinatorial chemistry promises to provide structure and activity data on a scale never before imagined, but it will do so only if one can characterize what one makes.

The task for the analytical community, then, is to develop methods of separating and characterizing compounds suitable for the assembly-line scale of combinatorial chemistry. This book details the methods currently available and also discusses emerging techniques that could have a major impact. It covers the gamut from a concise introduction to the various methods of combinatorial synthesis (Weller) to a splendidly useful compendium of commercial resources (Brock and Andrews). In between, we are taken through clear and critical descriptions of mass spectrometry (Vouros and Hauser-Fang), I-R (Gremlich), and NMR (Shapiro) methods for high-throughout compound identification, including the difficulties inherent in dealing with mixtures of

Foreword

v

compounds that most combinatorial synthetic strategies produce. Detailed consideration of the mixture problem is the basis for subsequent chapters on chromatography (Swartz) and capillary electrophoresis (Krull, Gendreau, and Dai). The latter process is of particular interest because it is so open to miniaturization, and there seems little doubt that the laboratory of the future will eventually be on a chip. The remaining chapters treat the informationexplosion problem head-on. Nicell discusses techniques for managing the reams of data that an analytical lab will face when it deals with combinatorial libraries, and Kyranos and Chipman outline the various ways of screening libraries in a high-throughput fashion. Although the focus of the book is on analytical techniques, these latter chapters in particular make it an excellent introduction to the entire field of combinatorial chemistry.

It’s funny how the wheel comes around for scientific disciplines. At just about the time that chemistry as a whole, and perhaps analytical chemistry in particular, was being written off by some as a ‘‘mature field’’ unlikely to produce the kind of cutting-edge excitement of, say, neurobiology or human genetics, along comes combinatorial chemistry. The making, and characterizing, of molecules has once again been thrust into the heart of things, where it has been for almost 200 years. If we are living in the Information Age, then surely it is appropriate that the Central Science should become at last an information science. This book is a manifesto for the next Chemical Revolution.

Gregory A. Petsko

Gyula and Katica Tauber Professor of Biochemistry

Director, Rosenstiel Basic Medical Sciences Research Center

Brandeis University

Waltham, Massachusetts

Preface

Analytical techniques play a critical role in drug discovery by providing valuable information to control the identity, purity, and stability of potential drug candidates. These techniques, commonly in the form of chromatographic and spectroscopic methods, are routinely used in the pharmaceutical laboratory from the initial synthesis of a new chemical entity all the way through the development cycle to the manufacture and sale of a pharmaceutical product.

The use of analytical techniques in the burgeoning field of combinatorial chemistry is anything but routine. Combinatorial chemistry is a term that describes a set of tools for generating extensive chemical diversity rapidly and efficiently. It has been described as having the potential to revolutionize drug discovery. In the drug discovery process, large numbers of compounds are screened for potential biological activity. Combinatorial chemistry does not alter this process, but introduces a new step that greatly increases the molecular diversity available for screening. The unique way in which this diversity is produced, however, places new demands on the analytical methods used to analyze and produce the desired results. In addition, the sheer volume of information generated, and the manual labor that would be required, would be overwhelming if not for the development of information management systems and related techniques critical to the development of this field.

Following the introduction presented in Chapter 1, this book discusses the application and use of specific analytical techniques (mass, infrared, and nuclear magnetic resonance spectrometry, chromatography, and capillary electrophoresis) in the combinatorial chemistry field (Chapters 2–6). It also discusses how to make sense of the vast amounts of data generated (Chapter 7), details how the actual libraries of compounds produced are utilized (Chapter 8), and lists some of the vast commercial resources available to researchers in the field of combinatorial chemistry (Chapter 9).

vii

viii

Preface

Analytical Techniques in Combinatorial Chemistry is intended to provide specific details on how analytical techniques are brought to bear on the unique challenges presented in the combinatorial chemistry laboratory. It is aimed primarily at industrial and pharmaceutical chemists faced with the task of developing methods, analyzing the results, and documenting and/or managing the discovery process in a combinatorial setting. Since many major pharmaceutical companies are in the process of staffing combinatorial chemistry departments, this publication could also serve as a training and reference source, or perhaps a graduate-level textbook. While the book is not intended to be an exhaustive literature review, specific citations are examined that highlight the use of analytical techniques and the way in which they are utilized to solve the unique problems encountered. It presents a basic introduction to the field for a novice, while providing detailed information sufficient for an expert in a particular analytical techique.

In closing, I would like to thank several colleagues who have contributed to my efforts in the burgeoning field of drug discovery and combinatorial chemistry. They include Bob Pfeifer, Beverly Kenney, Bob Karol, Ray Crowley, Pat Fowler, Mike Balogh, John Hedon, and Eric Block of Waters Corporation (Milford, Massachusetts) as well as Steve Preece, Mark McDowall, and Andrew Brailsford of Micromass Limited (Manchester, United Kingdom). Special thanks also go to Carol, Kristina, and Robert of MCS (Uxbridge, Massachusetts) for their help and consideration in the preparation of this text.

Michael E. Swartz

Contents

Foreword Gregory A. Petsko

iii

Preface

vii

Contributors

xi

1.

An Introduction to Combinatorial Chemistry

1

 

Harold N. Weller

 

2.

The Use of Mass Spectrometry

29

 

Annette Hauser-Fang and Paul Vou´ros

 

3.

Infrared and Raman Spectroscopy

65

 

Hans-Ulrich Gremlich

 

4.

NMR Methods

77

 

Michael J. Shapiro

 

5.

The Role of Liquid Chromatography

113

 

Michael E. Swartz

 

6.

Capillary Electrophoresis in Combinatorial Library

 

 

Analysis

137

 

Ira S. Krull, Christina A. Gendreau, and Hong Jian Dai

 

7.

Finding a Needle in a Haystack: Information Management

 

 

for High-Throughput Synthesis of Small Organic Molecules

173

 

David Nickell

 

ix

x

Contents

8.Bioanalytical Screening Methodologies for Accelerated Lead

Generation and Optimization in Drug Discovery

193

James N. Kyranos and Stewart D. Chipman

 

9. Commercial Resources

219

Mary Brock and Mark Andrews

 

Index

297